We are live on ! Find out more
WINT

Windtree Therapeutics
WINT

Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

7 hedge funds and large institutions have $3.02M invested in Windtree Therapeutics in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

23% less capital invested

Capital invested by funds: $3.94M → $3.02M (-$925K)

50% less funds holding

Funds holding: 14 → 7 (-7)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

Holders
7
Holders Change
-7
Holders Change %
-50%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
–
Closed
7
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$170K
2
Northern Trust
Northern Trust
Illinois
+$85.1K
3
Renaissance Technologies
Renaissance Technologies
New York
+$85.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$85.1K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$255K
2
PAM
PVG Asset Management
Colorado
-$156K
3
Goldman Sachs
Goldman Sachs
New York
-$153K
4
FWM
Frontier Wealth Management
Missouri
-$137K
5
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$88K

WINT Hedge Fund Activity: Q3 2021 in Review

7 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics (WINT) for Q3 2021, worth a combined $3.02M — down 23% from $3.94M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of WINT and 0 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 4 added.

The largest buyer was Geode Capital Management, adding an estimated $170K. The largest seller was Millennium Management, exiting entirely with an estimated $255K sold.

  • 7 institutional investors held Windtree Therapeutics (WINT) as of Q3 2021, down from 14 in Q2 2021.
  • Funds reported $3.02M of Windtree Therapeutics stock for Q3 2021, down 23% quarter-over-quarter.
  • 0 funds opened new Windtree Therapeutics positions in Q3 2021 and 7 closed out, a net change of -7 holders.
  • The largest Windtree Therapeutics buyer in Q3 2021 was Geode Capital Management, an estimated $170K added.
  • The largest Windtree Therapeutics seller in Q3 2021 was Millennium Management, an estimated $255K sold.

Based on aggregated 13F filings for Q3 2021.